Description
UrgoStart Plus
Description
Innovative and patented dressing, developed by Urgo Laboratories, composed of two exclusive technologies: the TLC-NOSF matrix and poly-absorbent fibres.
It is composed of:
- A micro-adherent matrix of TLC-NOSF, formed by lipid-colloidal particles, polymers and an exclusive element; the NOSF (Nano-Oligosaccharide Factor) which reduces healing time. In addition, the poly-absorbent fibers in polyacrylate guarantee the debridement of the lesion (which is cleansed from slough, exudate and bacterial residues).
- A super absorbent layer.
- A water-repellent, vapour-permeable outer film.
This specific combination is patented.
It reduces healing time and cleanses the wound from slough, exudate and bacterial residues.
The TLC-NOSF matrix forms a gel when it comes into contact with the lesion, and reduces healing time by inhibiting excess metallo-proteases that cause degradation of the extracellular matrix. In addition, gelation creates a moist environment that promotes the action of key cells involved in the healing process (fibroblasts, keratinocytes and macrophages).
Upon contact with the wound, the poly-absorbent fibres of UrgoStart Plus gel. The dressing absorbs and traps slough, exudate and bacterial debris present in the wound bed, for autolytic debridement. In addition, the poly-absorbent fibres make the dressing highly cohesive, allowing for atraumatic, one-piece reduction and without pain for the patient.
The poly-absorbent fibres and super absorbent layer of UrgoStart Plus ensure high absorption capacity and exudate management, preventing maceration. The dressing can be used under a compression bandage, if prescribed. UrgoStart Plus has a highly conformable and non-occlusive hydrophobic external support, which allows correct adaptation to the shape of the wound. It also acts as a barrier to exogenous bacteria, as well as helping to prevent fluid leakage. Its high vapour permeability properties allow excess exudate to evaporate, preventing the risk of maceration. The dressing adapts to different body movements, ensuring patient comfort. Thanks to its transparency, it is possible to monitor fluid leakage and therefore perform dressing changes only when necessary.
UrgoStart Plus has multiple properties:
1) Healing properties:
- Reduction of healing time combined with cleansing of all elements present in the lesion (slough, exudate, bacterial residues);
- absorption of exudate;
- management of minor bleeding;
- creating and maintaining a moist environment that promotes the healing process;
- atraumatic removal;
- protection of the perilesional skin.
2) Comfort and ease of use:
- Painless removal.
- Highly conformable and easy to position dressing thanks to micro-adherence.
- A water-repellent and vapour-permeable external film.
The efficacy of TLC-NOSF in reducing healing time has been demonstrated in double-blind randomized controlled clinical trials and in an analysis of observational studies.
It is indicated for all stages of exuding lesions (from cleansing to complete healing), including chronic lesions (lower limb lesions, pressure sores, diabetic foot) and long-term acute lesions.
How to use
Lesion preparation:
- Cleanse the lesion according to the local treatment protocol then rinse with saline solution.
- If an antiseptic has been used previously, rinse the wound thoroughly with saline solution before applying UrgoSmart Plus.
- Carefully dry the perilesional skin.
- The use of UrgoSmart Plus does not obviate the need for associated mechanical removal, if necessary.
Application of the dressing:
- Remove the protective tabs.
- Apply the micro-adherent layer of UrgoStart Plus directly to the lesion.
- Apply an appropriate bandage or, if prescribed, a compression bandage.
Changing the dressing:
- Remove the dressing when it becomes saturated and cleanse the wound if necessary.
It is recommended to replace UrgoStart Plus every 1 or 2 days during the wound desloughing phase, and subsequently as necessary (up to 7 days) depending on the amount of exudate and the clinical state of the wound.
Discard any unused portions of the dressing.
Warnings
- The micro-adherent layer of UrgoStart Plus adheres to latex surgical gloves. It is therefore recommended to use the tabs to facilitate application.
- Because UrgoStart Plus includes a super absorbent layer, the central pad does not need to be cut.
- In the presence of clinical signs of local infection, it is recommended to carry out an antibacterial treatment (such as UrgoClean Ag) before applying UrgoStart Plus.
- In case of atypical lesions with signs of induration or hypergranulation, treatment with UrgoStart Plus should be used only after having verified the absence of malignancy associated with the lesion, in order not to delay the diagnosis.
- Given the absence of specific clinical analyses for Epidermolysis Bullosa (even in long-standing lesions), it is recommended not to use UrgoStart Plus.
- The action of the product in triggering the healing process may cause stinging or painful sensations at the beginning of treatment with UrgoStart plus. This does not usually lead to discontinuation of treatment.
- During cleansing, the lesion may appear to enlarge due to the effective removal of devitalized tissue.
- The simultaneous use of creams, ointments and emulsions is not recommended.
- UrgoStart Plus must not be used in a hyperbaric chamber.
- Sterile individual packages, single use only: reusing a single-use package may pose a risk of infection.
- Do not resterilize the dressing.
- Before use, make sure the sterile protective film is intact. Do not use if the package is damaged.
- UrgoStart Plus facilitates the management of minor bleeding. However, it should not be used as a surgical tampon in case of lesions with significant bleeding.
- To avoid delaying their optimal treatment, UrgoStart Plus is contraindicated in the case of tumorous and fistula lesions with deep abscess.
- Do not use in case of hypersensitivity to UrgoStart Plus.
Conservation
Validity with intact packaging: 36 months.
Format
10 pieces.
Code 552301
Innovative and patented dressing, developed by Urgo Laboratories, composed of two exclusive technologies: the TLC-NOSF matrix and poly-absorbent fibres.
It is composed of:
- A micro-adherent matrix of TLC-NOSF, formed by lipid-colloidal particles, polymers and an exclusive element; the NOSF (Nano-Oligosaccharide Factor) which reduces healing time. In addition, the poly-absorbent fibers in polyacrylate guarantee the debridement of the lesion (which is cleansed from slough, exudate and bacterial residues).
- A super absorbent layer.
- A water-repellent, vapour-permeable outer film.
This specific combination is patented.
It reduces healing time and cleanses the wound from slough, exudate and bacterial residues.
The TLC-NOSF matrix forms a gel when it comes into contact with the lesion, and reduces healing time by inhibiting excess metallo-proteases that cause degradation of the extracellular matrix. In addition, gelation creates a moist environment that promotes the action of key cells involved in the healing process (fibroblasts, keratinocytes and macrophages).
Upon contact with the wound, the poly-absorbent fibres of UrgoStart Plus gel. The dressing absorbs and traps slough, exudate and bacterial debris present in the wound bed, for autolytic debridement. In addition, the poly-absorbent fibres make the dressing highly cohesive, allowing for atraumatic, one-piece reduction and without pain for the patient.
The poly-absorbent fibres and super absorbent layer of UrgoStart Plus ensure high absorption capacity and exudate management, preventing maceration. The dressing can be used under a compression bandage, if prescribed. UrgoStart Plus has a highly conformable and non-occlusive hydrophobic external support, which allows correct adaptation to the shape of the wound. It also acts as a barrier to exogenous bacteria, as well as helping to prevent fluid leakage. Its high vapour permeability properties allow excess exudate to evaporate, preventing the risk of maceration. The dressing adapts to different body movements, ensuring patient comfort. Thanks to its transparency, it is possible to monitor fluid leakage and therefore perform dressing changes only when necessary.
UrgoStart Plus has multiple properties:
1) Healing properties:
- Reduction of healing time combined with cleansing of all elements present in the lesion (slough, exudate, bacterial residues);
- absorption of exudate;
- management of minor bleeding;
- creating and maintaining a moist environment that promotes the healing process;
- atraumatic removal;
- protection of the perilesional skin.
2) Comfort and ease of use:
- Painless removal.
- Highly conformable and easy to position dressing thanks to micro-adherence.
- A water-repellent and vapour-permeable external film.
The efficacy of TLC-NOSF in reducing healing time has been demonstrated in double-blind randomized controlled clinical trials and in an analysis of observational studies.
It is indicated for all stages of exuding lesions (from cleansing to complete healing), including chronic lesions (lower limb lesions, pressure sores, diabetic foot) and long-term acute lesions.
How to use
Lesion preparation:
- Cleanse the lesion according to the local treatment protocol then rinse with saline solution.
- If an antiseptic has been used previously, rinse the wound thoroughly with saline solution before applying UrgoSmart Plus.
- Carefully dry the perilesional skin.
- The use of UrgoSmart Plus does not obviate the need for associated mechanical removal, if necessary.
Application of the dressing:
- Remove the protective tabs.
- Apply the micro-adherent layer of UrgoStart Plus directly to the lesion.
- Apply an appropriate bandage or, if prescribed, a compression bandage.
Changing the dressing:
- Remove the dressing when it becomes saturated and cleanse the wound if necessary.
It is recommended to replace UrgoStart Plus every 1 or 2 days during the wound desloughing phase, and subsequently as necessary (up to 7 days) depending on the amount of exudate and the clinical state of the wound.
Discard any unused portions of the dressing.
Warnings
- The micro-adherent layer of UrgoStart Plus adheres to latex surgical gloves. It is therefore recommended to use the tabs to facilitate application.
- Because UrgoStart Plus includes a super absorbent layer, the central pad does not need to be cut.
- In the presence of clinical signs of local infection, it is recommended to carry out an antibacterial treatment (such as UrgoClean Ag) before applying UrgoStart Plus.
- In case of atypical lesions with signs of induration or hypergranulation, treatment with UrgoStart Plus should be used only after having verified the absence of malignancy associated with the lesion, in order not to delay the diagnosis.
- Given the absence of specific clinical analyses for Epidermolysis Bullosa (even in long-standing lesions), it is recommended not to use UrgoStart Plus.
- The action of the product in triggering the healing process may cause stinging or painful sensations at the beginning of treatment with UrgoStart plus. This does not usually lead to discontinuation of treatment.
- During cleansing, the lesion may appear to enlarge due to the effective removal of devitalized tissue.
- The simultaneous use of creams, ointments and emulsions is not recommended.
- UrgoStart Plus must not be used in a hyperbaric chamber.
- Sterile individual packages, single use only: reusing a single-use package may pose a risk of infection.
- Do not resterilize the dressing.
- Before use, make sure the sterile protective film is intact. Do not use if the package is damaged.
- UrgoStart Plus facilitates the management of minor bleeding. However, it should not be used as a surgical tampon in case of lesions with significant bleeding.
- To avoid delaying their optimal treatment, UrgoStart Plus is contraindicated in the case of tumorous and fistula lesions with deep abscess.
- Do not use in case of hypersensitivity to UrgoStart Plus.
Conservation
Validity with intact packaging: 36 months.
Format
10 pieces.
Code 552301
